Inherited β-Cell Dysfunction in Lean Individuals With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The syndromes comprising diabetes mellitus share the common feature of β-cell failure. Inheritance of β-cell failure is clear in patients diagnosed with the MODY (maturity-onset diabetes of the young, also referred to as monogenic diabetes in youth) syndromes (1), as well as in permanent neonatal diabetes mellitus (2) where mutations in genes essential for insulin secretion associate with elevated blood glucose. Causative alleles for β-cell dysfunction have been identified for the monogenic forms of diabetes. Likewise, a role for genes impacting glucose-stimulated insulin secretion has been proposed for some polygenic forms of diabetes mellitus. Genome-wide association studies have not associated single nucleotide polymorphisms (SNPs) in genes required for optimal insulin secretion with autoimmune type 1A diabetes. In contrast, latent autoimmune diabetes of adults has been associated with TCF7L2 (3), a gene associated with reduced insulin secretion (4). TCF7L2 is one of the most significant loci for type 2 diabetes (5) and, along with HNF1B / HNF4A (6) and KCNJ11 (7), tie genes involved in β-cell dysfunction to risk for developing type 2 diabetes in overweight individuals. In this issue of Diabetes , a new report (8) proposes that a recently identified type 2 diabetes risk gene is linked to dysfunctional glucose-stimulated insulin secretion (GSIS) in lean Japanese patients with type 2 diabetes. Lean type 2 diabetes is highly prevalent in Japan …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been well established that Asians are at increased risk of non-overweight T2D. In Japan, more than 50% of patients have a BMI of under 25, but they have more abdominal fat at the equivalent BMI to Caucasians.35,71”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [35]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It has been well established that Asians are at increased risk of non-overweight T2D. In Japan, more than 50% of patients have a BMI of under 25, but they have more abdominal fat at the equivalent BMI to Caucasians.35,71”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [35]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“It has been well established that Asians are at increased risk of non-overweight T2D. In Japan, more than 50% of patients have a BMI of under 25, but they have more abdominal fat at the equivalent BMI to Caucasians.35,71”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [35]
Experimental — accuracy not yet measuredIn the citing paper
“and other Asian countries also have a high percentage of T2D patients with a BMI of <25.35”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [35]
In the citing paper
“However, in some Asian countries, ~50% of patients are not overweight.34,35”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287 · cited 1×
“TCF7L2 is one of the most significant loci for type 2 diabetes (5) and, along with HNF1B/HNF4A (6) and KCNJ11 (7), tie genes involved in b-cell dysfunction to risk for developing type 2 diabetes in overweight individuals.”
BackgroundGloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032922 · Cited by 1,137 · cited 1×
“Inheritance of b-cell failure is clear in patients diagnosed with the MODY (maturity-onset diabetes of the young, also referred to as monogenic diabetes in youth) syndromes (1), as well as in permanent neonatal diabetes mellitus (2) where mutations in genes essential for insulin secretion associate with elevated blood…”
BackgroundA genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion
Ravassard, P., Hazhouz, Y., Pechberty, S., Bricout-Neveu, E., Armanet, M., Czernichow, P., & Scharfmann, R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58447 · Cited by 576
TCF7L2 Regulates Late Events in Insulin Secretion From Pancreatic Islet β-Cells
da Silva Xavier, G., Loder, M. K., McDonald, A., Tarasov, A. I., Carzaniga, R., Kronenberger, K., Barg, S., & Rutter, G. A. (2009) · Diabetes · doi:10.2337/db08-1187 · Cited by 207 · cited 1×
“In contrast, latent autoimmune diabetes of adults has been associated with TCF7L2 (3), a gene associated with reduced insulin secretion (4).”
BackgroundWaters, K. M., Stram, D. O., Hassanein, M. T., Le Marchand, L., Wilkens, L. R., Maskarinec, G., Monroe, K. R., Kolonel, L. N., Altshuler, D., Henderson, B. E., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001078 · Cited by 191 · cited 1×
“TCF7L2 is one of the most significant loci for type 2 diabetes (5) and, along with HNF1B/HNF4A (6) and KCNJ11 (7), tie genes involved in b-cell dysfunction to risk for developing type 2 diabetes in overweight individuals.”
BackgroundReplication Study of Candidate Genes Associated With Type 2 Diabetes Based On Genome-Wide Screening
Tabara, Y., Osawa, H., Kawamoto, R., Onuma, H., Shimizu, I., Miki, T., Kohara, K., & Makino, H. (2009) · Diabetes · doi:10.2337/db07-1785 · Cited by 146
Pessia, M., Imbrici, P., D’Adamo, M. C., Salvatore, L., & Tucker, S. J. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0359f.x · Cited by 135 · cited 1×
“KCNJ15 appears to have a major role in renal function (15,16), and diabetic patients represent a population at increased risk for renal failure (17).”
BackgroundFactors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes
Ueda, H., Ishimura, E., Shoji, T., Emoto, M., Morioka, T., Matsumoto, N., Fukumoto, S., Miki, T., Inaba, M., & Nishizawà, Y. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1530 · Cited by 76 · cited 1×
“KCNJ15 appears to have a major role in renal function (15,16), and diabetic patients represent a population at increased risk for renal failure (17).”
BackgroundMONOGENIC DIABETES MELLITUS IN YOUTH
Winter, W. E., Nakamura, M., & House, D. V. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70101-8 · Cited by 74 · cited 1×
“Inheritance of b-cell failure is clear in patients diagnosed with the MODY (maturity-onset diabetes of the young, also referred to as monogenic diabetes in youth) syndromes (1), as well as in permanent neonatal diabetes mellitus (2) where mutations in genes essential for insulin secretion associate with elevated blood…”
BackgroundPrato, S. D., LaSalle, J. R., Matthaei, S., Bailey, C. J., & Management, O. B. O. T. G. P. F. E. D. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02227.x · Cited by 66
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Diabetes: A metabolic and reproductive disorder in women
Thong, E. P., Codner, E., Laven, J. S. E., & Teede, H. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30345-6 · Cited by 242
Body Mass Index, Diabetes, and the Risk of Parkinson's Disease
Jeong, S., Han, K., Kim, D., Rhee, S. Y., Jang, W., & Shin, D. W. (2019) · Movement Disorders · doi:10.1002/mds.27922 · Cited by 110
“DM developed in the underweight group and was associated with impaired insulin secretion, and lean DM patients had a low level of fasting insulin.(34) Conversely, DM in obese individuals is mainly attributable to insulin resistance, and their insulin secretion is increased.”
BackgroundTanabe, H., Masuzaki, H., & Shimabukuro, M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109067 · Cited by 62
Olaogun, I., Farag, M. S., & Hamid, P. (2020) · Cureus · doi:10.7759/cureus.7614 · Cited by 62
Forcada, Y., Holder, A. L., Church, D. B., & Catchpole, B. (2013) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12275 · Cited by 34
Fan, Y., Fan, B., Lau, E. S. H., Lim, C. K. P., Wu, H., Ronald, C. W., Ozaki, R., Kong, A. P. S., Chow, E., Luk, A. O. Y., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110954 · Cited by 28
Jung, M., Yi, S., An, S. J., Balkau, B., Yi, J., & Kim, H. (2020) · Diabetologia · doi:10.1007/s00125-020-05160-1 · Cited by 14
Etiologies underlying subtypes of long-standing type 2 diabetes
Bayoumi, R., Farooqi, M. H., Alawadi, F., Hassanein, M. M., Osama, A., Mukhopadhyay, D., Abdul, F., Sulaiman, F., Dsouza, S., Mulla, F., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304036 · Cited by 11
Prince, L., Andrews, J. R., Basu, S., & Goldhaber‐Fiebert, J. D. (2016) · Tropical Medicine & International Health · doi:10.1111/tmi.12763 · Cited by 6
Diabetes Mellitus and Infertility
Christou, M., Kalpatsanidis, A., & Kolibianakis, E. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-89243-2_20 · Cited by 4
Cytoskeleton Dynamics in Health and Disease: Role of Molecular Switches and Rheostats
Osman, M. A. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2904-7_2 · Cited by 7
Emerging therapeutic approaches in neurobiology of type 2 diabetes
Kumar, U., Garg, S., Shrivastav, A., Sharma, B., Arora, B., Sahu, B., & Gupta, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-32848-0.00023-6
Pîrșcoveanu, D. F. V., Pluta, I. D., Dîrnu, R., Vlădulescu, C., Trașcă, D.-M., Văruț, R. M., Kamal, A. M., Stoica, M., Pura, G., Popa, R., et al. (2026) · Molecules · doi:10.3390/molecules31142415
“Its development is strongly associated with obesity and dietary excess in many populations [171–175], although substantial heterogeneity exists across ethnic and geographic groups, indicating that T2DM cannot be reduced to a single phenotypic or genetic pattern [176–179].”
Metadata
- Authors
- Mathews, A. E. W., & Mathews, C. E.
- Affiliations
- University of Florida (US)
- University of Florida Health (US)
- Corresponding author
- Mathews, Clayton E.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-06-15
- Volume
- 61
- Issue
- 7
- Pages
- 1659-1660
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3379645
- OpenAlex
- W2165015887
- Cited by
- 14
- References
- 17
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 2 · 2016: 1 · 2015: 1 · 2013: 1
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (UL1TR000064)
- National Institute of Allergy and Infectious Diseases (P01AI042288)
- National Institute of Diabetes and Digestive and Kidney Diseases (R56DK074656, DK-074656, R01DK074656)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- type 2 diabetes, beta-cell dysfunction, lean individuals, glucose-stimulated insulin secretion, genetic susceptibility, TCF7L2, monogenic diabetes, latent autoimmune diabetes in adults, HNF1B, KCNJ11, Japanese patients
- MeSH terms
- Insulin Secretion, Animals, Diabetes Mellitus, Type 2, Female, Glucose, Humans, Insulin, Male, Genetic Predisposition to Disease, Potassium Channels, Inwardly Rectifying
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.